The safety profiles are similarly favourable
Read our Certificate of Analysis (CoA)
These mechanisms improve glycemia and consistently produce clinically meaningful weight loss (Nauck & Meier, 2020)
Then, the blots were incubated with the following antibodies overnight at 4 C: mouse anti-GLP-1R (1:200, Santa Cruz, CA, USA), mouse anti-GLP-1 (1:100, Santa Cruz, CA, USA), mouse anti-CGRP (1:100, Santa Cruz, CA, USA), mouse anti-c-fos (1:200, Santa Cruz, CA, USA), rabbit anti-Iba-1 (1:1000, Abcam, Cambridge, MA, USA), rabbit anti-PI3K (1:1000, Proteintech, China), rabbit anti-Akt (1:1000, Proteintech, China), rabbit anti-phospho-Akt (1:2000, Cell Signalling, Boston, MA, USA), rabbit anti-IL-1 (1:800, Wanleibio, China), rabbit anti-TNF- (1:800, Wanleibio, China), and mouse anti--actin (1:1000, Beyotime, China)
Healthcare providers often recommend continuing the program until clients achieve their target weight and establish healthier eating and activity patterns
Final Thoughts GLP-1 side effects are common at the start of treatment but are usually mild and temporary
